Elbonix 50mg Tablets 28s
| Manufacturer | Novartis Pharma Pakistan |
| Active Ingredients | Eltrombopag Olamine |
| Medicine Strength | 50mg per Tablet |
| Formulation | Film-Coated Tablets |
| Requires Prescription? | Yes (Hematologist prescription required) |
| Generics | Eltrombopag |
Elbonix Ingredients and Usage
The active ingredient is Eltrombopag Olamine, an oral thrombopoietin receptor agonist. The 50mg tablet is taken once daily on an empty stomach at least 1 hour before or 2 hours after food.Elbonix is clinically indicated for:Chronic immune thrombocytopenia in adult patients
Severe aplastic anemia treatment
Patients refractory to other ITP treatments
Hepatitis C-associated thrombocytopenia
How Does Elbonix Work?
Elbonix provides enhanced platelet stimulation through targeted mechanisms:TPO Receptor Activation: Binds to transmembrane domain of thrombopoietin receptor
JAK-STAT Pathway Stimulation: Activates intracellular signaling pathways
Megakaryocyte Proliferation: Increases bone marrow megakaryocyte production
Platelet Maturation: Promotes differentiation into functional platelets
Elbonix Side Effects and Warnings
Common side effects include headache, nausea, diarrhea, and elevated liver enzymes. Most effects are dose-dependent and reversible.Serious Considerations
Hepatotoxicity Monitoring: Regular liver function tests essential
Bone Marrow Reticulin: Risk of increased bone marrow fibrosis
Thrombotic Complications: Increased risk with elevated platelet counts
Cataract Formation: Regular eye examinations recommended
Dosing Adjustment: Based on platelet response and liver function
Elbonix Storage Conditions
Elbonix Tablets require proper storage conditions:Store at room temperature below 30°C
Keep in original blister packaging
Protect from moisture and light
Keep out of reach of children
Do not use after expiration date
No reviews yet. Be the first to review this product!
Login to write a review